New strategies aim to boost HPV shots in florida teens
NCT ID NCT05677360
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests ways to increase HPV vaccination among 11-17 year olds at 8 community health centers in Florida. It provides training for doctors and nurses on how to recommend the vaccine, and gives parents easy-to-understand information before visits. The goal is to see if these strategies help more teens start and complete the HPV vaccine series, which can prevent several types of cancer.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- behavioral intervention (training for providers and educational materials for parents)
- What this could lead to
- If successful, this could show how to significantly boost HPV vaccination rates in underserved communities, helping prevent HPV-related cancers.
- What could go wrong
- The study is currently suspended, so results may be delayed or not completed. It focuses on behavioral changes, not a new medical treatment, so impact depends on real-world adoption.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 564 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2023
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * For Staff: * 18 years of age or older * Working within the participating Federally Qualified Health Center system * Able to read, write and speak English * For Providers: * 18 years of age or older * Working within the participating Federally Qualified Health Center system * Interacting with parents of adolescents ages 11-17 * Able to read, write and speak English * For parents: * Parent of 11-17 year old child that has received care within the prior two months at one of the participating Federally Qualified Health Centers * Whose child has not initiated or completed the HPV vaccine series at the time of their last visit * Able to read, write and speak English or Spanish, or Haitian Creole
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Human papilloma virus (HPV) vaccine are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States